Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.
about
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks.Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.MABp1 for the treatment of colorectal cancer.A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.The Importance of Dendritic Cells in Maintaining Immune Tolerance.Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.A Protective Role for Interleukin-1 Signaling during Mouse Adenovirus Type 1-Induced Encephalitis.Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.Innate immunity and inflammation.Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.Ebosin: a potential therapeutic agent for rheumatoid arthritis and autoinflammatory syndromes.Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice.IgG is elevated in obese white adipose tissue but does not induce glucose intolerance via Fcγ-receptor or complement.Integrative Approaches to Understand the Mastery in Manipulation of Host Cytokine Networks by Protozoan Parasites with Emphasis on Plasmodium and Leishmania Species.Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses.Type I interferons in tuberculosis: Foe and occasionally friend.Drug-induced sarcoidosis in a patient treated with an interleukin-1 receptor antagonist for hidradenitis suppurativa.Investigating Functional Roles for Positive Feedback and Cellular Heterogeneity in the Type I Interferon Response to Viral InfectionInflammasomes in Tissue Damages and Immune Disorders After Trauma
P2860
Q37584275-CBF36A50-E16E-4BA4-8CB4-6FED748EAD14Q38668279-3EE268B8-9AB9-468E-B2CF-DA5DCFA9194EQ38686881-F890C9BB-B30F-40EA-8E3E-DA1782744BD9Q38773387-4E4EDCA8-5D1A-45EC-8CE4-997629E6B8CFQ38893448-F5F8209B-AD16-40A5-8A1D-E1E69DFB1AC9Q39164401-FCD40F58-598C-41B6-B4C9-C0B352F07C80Q40064394-13672EC5-AF4D-4078-8341-18B4A887969DQ40428870-CBB26972-F786-46C7-9E18-B65642E0BB4FQ41920055-BDA4775A-FBF4-4683-A58A-BB060080B226Q48103184-21756BF6-FA93-4271-822A-B8F02C55B07DQ49447299-E9E97BBB-2A1B-4AF2-9773-5CD8C3DBBB8DQ50049021-32C5E7E3-9B78-4507-ACDA-67805F1A2351Q50130514-22CAF290-BEF1-4E73-BC65-C9BABCD4B31CQ50276949-6C6C21F2-295A-4FFE-A60B-F68258BF2794Q51148229-6E5C475D-D6B0-40D6-8DF1-066A60FF1F73Q52646149-2CBB52F0-ECF9-43D8-8198-79E44FDB3CD0Q54233818-987E8CDA-34DC-44F4-A0F2-6BD25DB30703Q55112626-88EE6DCA-9F9E-458C-B687-0059FE7087F4Q58702408-5453BD46-C213-4DC2-90AE-18CFCC496C2DQ58773658-4862A381-899E-4F37-8216-7EB61504749B
P2860
Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@en
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@nl
type
label
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@en
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@nl
prefLabel
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@en
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@nl
P2860
P921
P356
P1476
Clash of the Cytokine Titans: ...... diated inflammatory responses.
@en
P2093
Katrin D Mayer-Barber
P2860
P2888
P356
10.1038/CMI.2016.25
P577
2016-06-06T00:00:00Z
2017-01-01T00:00:00Z